In a report released on January 13, Faisal Khurshid from Leerink Partners reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report). The company’s shares closed yesterday at $54.16.

Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective raised by Leerink Partners from $18.00 to $20.00 in a research report issued to clients and investors on Monday ...

ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) had its price target lifted by investment analysts at Leerink Partners from $26.00 to $27.00 in a report released on Monday,Benzinga reports.

"Although this is the second quarter in a row of disappointing results, we expect 2025+ financial performance and pipeline news flow (specifically oral GLP-1 orforglipron Ph3 results) to be ...

‘Jackass’ star and former skateboarder Bam Margera shares a son with his ex-wife Nicole ‘Nikki’ Boyd Emma Kershaw is ... television personality Phil Margera, visiting his grandson while ...

A minor uptick in Leerink Partners’ price target to $87 followed AstraZeneca’s strong third-quarter performance, with revenue reaching $13.565 billion – exceeding projections by 4%.

Margera told Dr. Phil that Phoenix continues to be his north star and encouragement to be sober. “If I didn’t see Phoenix, who knows where I’d be," he said. After almost 10 years together, Margera and ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...